Kathleen Brady to Opiate Substitution Treatment
This is a "connection" page, showing publications Kathleen Brady has written about Opiate Substitution Treatment.
Connection Strength
1.301
-
Treatment of Opioid Use Disorder in Pregnant Women via Telemedicine: A Nonrandomized Controlled Trial. JAMA Netw Open. 2020 01 03; 3(1):e1920177.
Score: 0.646
-
Retention in Treatment after Emergency Department-Initiated Buprenorphine. J Emerg Med. 2021 09; 61(3):211-221.
Score: 0.179
-
Rates of substance use disorder treatment seeking visits after emergency department-initiated buprenorphine. Am J Emerg Med. 2020 05; 38(5):975-978.
Score: 0.163
-
Assessing the needs of front-line providers in addressing the opioid crisis in South Carolina. J Subst Abuse Treat. 2020 01; 108:4-8.
Score: 0.155
-
Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):313-23.
Score: 0.091
-
Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder. Contemp Clin Trials. 2021 06; 105:106394.
Score: 0.044
-
Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA. 2012 Aug 15; 308(7):690-9.
Score: 0.024